Hosted on MSN45m
J&J Pauses Sales of Atrial Fibrillation Device, Stock Down
Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to ...
The Pharma Letter48m
MitoRx strengthens team as obesity program advances
MitoRx Therapeutics strengthens its leadership with the appointments of Lubor Gaal as chief business officer and Stacey ...